 
                                            Palomar Holdings, Inc. Announces Agreement to Acquire The Gray Casualty & Surety Company Builds Scale in the Attractive Surety Market LA JOLLA, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Palomar Holdings, Inc. (NASDAQ: PLMR) (“Palomar”, the “Company”) today announced that it has entered into a definitive agreement to acquire The Gray Casualty & Surety Company (“Gray Surety”) from Bernhard Capital Partners (“BCP”) and The Gray Insurance Company for total consideration of $300 million in cash subject to customary closing adjustments. The transaction has been approved by both Gray Surety an...
 
                                            Palomar Holdings, Inc. Announces Third Quarter 2025 Financial Results Release Date and Conference Call LA JOLLA, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Palomar Holdings, Inc. (NASDAQ: PLMR) (the “Company”) today announced that it will release its third quarter 2025 results after market close on Thursday, November 6, 2025, and will host a conference call at 12:00 p.m. (Eastern Time) the following day, Friday, November 7, 2025. The conference call can be accessed live by dialing 1-877-423-9813 or for international callers, 1-201-689-8573, and requesting to be joined to the Palomar Third...
 
                                            Rhythm Pharmaceuticals to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 BOSTON, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, November 4, 2025 to report its third quarter 2025 financial results and provide a corporate update. To access the live conference call, participants may register . While n...
 
                                            ARRAY Technologies, Inc. Announces Third Quarter 2025 Earnings Release Date and Conference Call ALBUQUERQUE, N.M., Oct. 16, 2025 (GLOBE NEWSWIRE) -- ARRAY Technologies, Inc. (the “Company” or “ARRAY”) (NASDAQ: ARRY), a leading global provider of solar tracking technology and fixed-tilt system products, software, services and foundation solutions, today announced that the Company will release its third quarter 2025 results after the market closes on Wednesday, November 5, 2025, to be followed by a conference call at 5:00 p.m. (Eastern Time) that same day. The conference call can be access...
 
                                                                                In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
 
                                                                                In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
 
                                                                                A director at Geo Group Inc sold 93,528 shares at 20.850USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
 
                                            ARRAY Technologies Confirms Compatibility with 2000-Volt Solar Projects Technical evaluation verifies DuraTrack® and OmniTrack™ systems meet industry standards for next-generation solar installations ALBUQUERQUE, N.M., Sept. 03, 2025 (GLOBE NEWSWIRE) -- ARRAY Technologies (NASDAQ: ARRY) (“ARRAY” or the “Company”), a leading global provider of solar tracking technology products, software, services and foundation solutions, announced today that its DuraTrack® and OmniTrack™ systems have been verified by Intertek to be compatible with 2000-volt (2kV) module-wired systems. This milestone re...
 
                                            Palomar Holdings, Inc. Announces Participation in the 2025 KBW Insurance Conference LA JOLLA, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Palomar Holdings, Inc. (NASDAQ: PLMR) (“Palomar”) today announced that Mac Armstrong, Chairman and Chief Executive Officer, and Chris Uchida, Chief Financial Officer, will participate in a fireside chat at the KBW Insurance Conference on Thursday, September 4, 2025 at 10:35 am ET. Management will also be available for one-on-one and small group meetings with investors. Interested investors and other parties can access a live webcast of the presentation b...
 
                                            Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences BOSTON, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that David Meeker, M.D., Chair, President and Chief Executive Officer, will participate in fireside chats at two upcoming investor conferences: Wells Fargo Healthcare Conference on Wednesday, September 3, 2025 at 9:30 a.m. ETMorgan Stanley Global Healthcare Conference on...
 
                                            Rhythm Pharmaceuticals Announces FDA Acceptance of sNDA for Setmelanotide in Acquired Hypothalamic Obesity – U.S. Food and Drug Administration accepts sNDA for filing with priority review; sets PDUFA goal date of December 20, 2025 -- – European Medicines Agency accepts and validates submission for Type II variation MAA for setmelanotide to treat acquired hypothalamic obesity – – Company to host “Commercial Readiness for Acquired Hypothalamic Obesity,” event for investors and analysts on Wednesday, September 24, in Boston – BOSTON, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceutical...
 
                                            ARRAY Technologies Completes Acquisition of APA Solar Combined product portfolio positions ARRAY to deliver fully integrated tracker and engineered foundation solutions for the solar industry ALBUQUERQUE, N.M., Aug. 14, 2025 (GLOBE NEWSWIRE) -- ARRAY Technologies (NASDAQ: ARRY) (“ARRAY” or the “Company”), a leading global provider of solar tracking technology products, software, and services for utility-scale solar energy projects, today announced the successful completion of its acquisition of APA Solar (“APA”), a premier solar racking and structural solutions provider. This strategic ...
 
                                            ARRAY Technologies, Inc. to Participate in Upcoming Investor Conferences and Events ALBUQUERQUE, N.M., Aug. 12, 2025 (GLOBE NEWSWIRE) -- ARRAY Technologies (NASDAQ: ARRY) (“ARRAY” or the “Company”), a leading global provider of solar tracking technology products, software and services, today announced its attendance at the following upcoming investor events: Citi’s 2025 Natural Resources Conference August 14, 2025 in Las VegasARRAY’s CFO, H. Keith Jennings, will host in-person investor meetings. Interested investors should contact their Citi sales representative. Barclays 39th Annual En...
 
                                            ARRAY Technologies, Inc. Reports Financial Results for the Second Quarter 2025 Commercial excellence continues to deliver, year-to-date volume growth up 84% over 2024 2025 Second Quarter Highlights Revenue of $362.2 millionGross Margin of 26.8%Adjusted gross margin(1) of 27.8%Net income to common shareholders of $28.5 millionAdjusted EBITDA(1) of $63.6 millionNet income per basic and diluted share of $0.19Adjusted net income per diluted share(1) of $0.25Total executed contracts and awarded orders at June 30, 2025 were over $1.8 billion Inclusive of strategic descoping and reconfigu...
 
    
 
            Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.